Radiopharm Theranostics Ltd (RADX) stock
RADXNasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as RDPTF
$0.69+0.01 (+2.10%)
Close on Nov 18, 2026Market cap $8.09MP/E –Yield –
Radiopharm Theranostics net income
Net income is the profit left for shareholders after every expense, interest and tax.
No net income figures for Radiopharm Theranostics
Radiopharm Theranostics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?